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Abstract
In clinical settings, there is a high comorbidity between substance use disorders, psychiatric 
disorders, and traumatic stress. As such, transdiagnostic therapies are needed to address these co-
occurring issues efficiently. The aim of the present study was to conduct a pragmatic randomized 
controlled trial comparing Mindfulness-Oriented Recovery Enhancement (MORE) to group 
Cognitive-Behavioral Therapy (CBT) and treatment-as-usual (TAU) for previously homeless men 
residing in a therapeutic community. Men with co-occurring substance use and psychiatric 
disorders, as well as extensive trauma histories, were randomly assigned to 10 weeks of group 
treatment with MORE (n=64), CBT (n=64), or TAU (n=52). Study findings indicated that from 
pre- to post-treatment MORE was associated with modest yet significantly greater improvements 
in substance craving, post-traumatic stress, and negative affect than CBT, and significantly greater 
improvements in post-traumatic stress and positive affect than TAU. A significant indirect effect 
of MORE on decreasing craving and post-traumatic stress by increasing dispositional mindfulness 
was observed, suggesting that MORE may target these issues via enhancing mindful awareness in 
everyday life. This pragmatic trial represents the first head-to-head comparison of MORE against 
an empirically-supported treatment for co-occurring disorders. Results suggest that MORE, as an 
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integrative therapy designed to bolster self-regulatory capacity, may hold promise as a treatment 
for intersecting clinical conditions.
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Of the estimated 2.5 – 3.5 million homeless individuals in the United States annually 
(Kilgore, 2013), pooled prevalence estimates suggest that 24% to 38% have substance use 
disorders (Fazel, Khosla, Doll, & Geddes, 2008), and one study identified a lifetime 
prevalence rate of 23% for co-occurring substance use and psychiatric disorders (SAMHSA, 
2015). Moreover, there is substantial comorbidity of post-traumatic stress disorder (PTSD) 
and substance use disorders among the homeless, with estimates ranging from 16 to 19% 
(Torchalla et al., 2014). The co-occurrence of psychiatric and substance use disorders is 
associated with increased risk of relapse, recurrent psychological symptoms, and poor 
prognosis (Flynn & Brown, 2008). Despite having significant psychiatric needs, less than 
half of individuals with co-occurring disorders (COD) in need of treatment receive it 
(SAMHSA, 2015).
Individuals with COD tend to have high rates of exposure to stressful and traumatic life 
events with which they often cope through alcohol and drug use as a form of self-medication 
(Khantzian, 1997; Leeies, Pagura, Sareen, & Bolton, 2010). To the extent that psychoactive 
agents may temporarily relieve distress, self-medication can become negatively reinforcing 
(Baker, Piper, McCarthy, Majeskie, & Fiore, 2004), resulting in entrenchment of this coping 
pattern as an addictive response subject to reactivation by future stressors (Garland, 
Boettiger, & Howard, 2011). Consequently, substance use becomes compulsive, resulting in 
a powerful conditioned response mediated by the mesocorticolimbic dopamine system that 
is subjectively experienced as craving (Skinner & Aubin, 2010). In turn, craving coupled 
with negative affect may promote chronic substance use, which in turn renders the 
individual increasingly sensitized to stress and desensitized to pleasure from naturally-
rewarding objects and events (Koob, 2008; Koob & Le Moal, 2001). This process, known as 
allostasis, results in an overall hedonic deficit, manifested in negative affective states which 
impel the individual to imbibe increasingly higher doses of the substance to achieve a 
dwindling sense of well-being.
These reciprocally-energizing linkages between psychiatric distress, substance use, and 
trauma symptoms make COD especially difficult to treat (Najavits, 2002). Though 
community-based treatment agencies typically adopt a sequential approach to treating these 
interlocking issues, integrated treatment approaches are heralded as best practices. Despite 
the prevalence and consequences of COD, few integrated, empirically-supported treatment 
options are available, and even fewer have been tested as interventions for homeless 
individuals in randomized controlled trials (RCTs). Among interventions for COD currently 
employed in the U.S., Seeking Safety (Najavits, 2002; Najavits, Weiss, Shaw, & Muenz, 
1998) has perhaps the strongest evidence base. This cognitive-behavioral therapy (CBT), 
which was specifically designed to target the co-occurrence of PTSD and substance use 
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disorders, has been shown in RCTs to significantly improve PTSD and substance use 
disorder symptoms (Najavits & Hien, 2013).
Despite the considerable success of Seeking Safety, CBT interventions may not be effective 
for all homeless individuals with COD and histories of trauma. Indeed, clients who suffer 
from mood and anxiety disorders (in addition to PTSD symptoms) might benefit from other 
therapies which target a broad spectrum of cognitive, affective, behavioral, and 
physiological processes underpinning psychopathology (Garland & Howard, 2013a). In that 
regard, mindfulness-based interventions (MBIs) may be especially efficacious. Meta-
analyses have found MBIs to outperform non-specific active control conditions and produce 
significant effects on depressive and anxious symptomatology (Goyal et al., 2014). RCTs 
have revealed significant effects of MBIs on substance use disorders (Bowen et al., 2014; 
Chiesa & Serretti, 2014). Although less evidence is available with regard to the effects of 
MBIs on post-traumatic stress symptoms, quasi-experimental (Kearney, McDermott, Malte, 
Martinez, & Simpson, 2013; King et al., 2013) studies have found significant improvements 
in post-traumatic stress associated with participation in MBIs, and a recent wait-list RCT 
found large-effect size reductions in post-traumatic stress and depressive symptoms among 
female survivors of interpersonal violence following treatment with a trauma-informed MBI 
(Kelly & Garland, in press). Taken together, these studies suggest that MBIs might be useful 
for ameloriating COD.
As an exemplar MBI, Mindfulness-Oriented Recovery Enhancement (MORE) was designed 
to target mechanisms linking stress-related conditions and addiction (Garland, 2013). 
MORE unites complementary aspects of mindfulness training, CBT, and principles from 
positive psychology into an integrative treatment approach. MORE differs from other MBIs 
in that it integrates formal mindfulness meditation practice with cognitive reappraisal and 
savoring techniques. At present, MORE has been tested in two early-stage RCTs. In the first 
trial, MORE was tested as a treatment for alcohol dependent adults (N=53) in long-term 
residential treatment (Garland, Gaylord, Boettiger, & Howard, 2010). Results indicated that 
compared to a support group control condition, MORE was associated with significantly 
greater reductions in perceived stress and thought suppression, as well as significantly 
greater autonomic nervous system recovery from stress and alcohol cue-exposure at post-
treatment. In a second trial, a modified version of MORE was tested as a treatment for 
prescription opioid misuse among chronic pain patients prescribed long-term opioid 
analgesics (N=115) (Garland, Manusov, et al., 2014). Compared with a support group 
control condition, participants in MORE evidenced significantly greater reductions in stress 
arousal and opioid craving, and were significantly more likely to no longer meet criteria for 
opioid use disorder at post-treatment.
Subsequent mechanistic studies indicated that participation in MORE was associated with 
significant reductions in attentional bias for emotionally-threatening cues (Garland & 
Howard, 2013b), significant improvements in autonomic regulation during attention to 
emotional information (Garland, Froeliger, & Howard, 2014a), and significant increases in 
cardiac (Garland, Froeliger, et al., 2014a), and electrocortical indices of natural reward 
processing (Garland, Froeliger, & Howard, 2014b). Further, MORE appears to exert 
addiction-specific effects, including decreasing the correlation strength between drug 
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craving and addictive behavior (Garland, Manusov, et al., 2014), and reducing drug cue-
reactivity (Garland, Froeliger, et al., 2014a). The effects of MORE on these mechanisms 
indicates its promise as an intervention for COD, yet MORE’s efficacy relative to other 
treatments for COD has not been established.
As such, we conducted a pragmatic trial to compare MORE as a treatment for substance 
dependent individuals with trauma histories to a group cognitive-behavioral therapy (CBT) 
intervention, as well as treatment-as-usual (TAU) in a modified therapeutic community 
environment. In contrast to explanatory clinical trials which measure treatment efficacy 
under ideal conditions, pragmatic trials evaluate the benefit of treatments as delivered in 
routine clinical practice (Roland & Torgerson, 1998). Given its therapeutic mechanisms, we 
hypothesized that MORE would produce greater improvements in primary outcomes 
including craving, post-traumatic stress symptoms, and psychiatric distress than CBT or 
TAU. With regard to secondary outcomes, we hypothesized that MORE would produce 
greater improvements in dispositional mindfulness and positive and negative affect than 
CBT or TAU. Because participants varied with regard to their readiness to change, it was 
important to consider the effect of this factor on treatment outcomes. A meta-analysis 
including 8238 patients found a clinically significant effect size (d=.46) for the association 
between stage of change and psychotherapy outcomes, including outcomes directly relevant 
to PTSD and COD (Norcross, Krebs, & Prochaska, 2011). As such, we controlled for 
readiness to change in outcome analyses.
METHODS
Participants and procedure
Men with co-occurring substance use and psychiatric disorders were recruited for this study 
from a modified therapeutic community in an urban area in the Southeastern United States. 
This modified therapeutic community involved a two-year-long program, in which clients 
graduate through various phases of treatment and vocational training. Inclusion criteria 
were: 1) age ≥18 years; 2) current substance use disorder diagnosis and current psychiatric 
disorder diagnosis as defined by the Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition; and 3) homelessness prior to entering into the therapeutic community. 
Individuals were excluded with 1) active psychosis and 2) substance withdrawal during 
informed consent. Diagnostic criteria were assessed with a semi-structured psychiatric 
interview similar to the Mini-International Neuropsychiatric Interview (MINI) (Sheehan et 
al., 1998), which differed in that it included a broader array of DSM-IV TR categories not 
assessed by the MINI (e.g., dysthymia, specific phobia, etc.). Diagnostic interviews were 
conducted by a psychiatrist and/or clinical social worker with training in making addiction 
and psychiatric disorder diagnoses.
Following admission into the therapeutic community (which entailed an orientation to the 
program and the diagnostic assessment), potential participants were approached about the 
study and provided informed consent, after which they completed a series of validated 
questionnaires in a pre-treatment assessment session administered by a research assistant. 
Because MORE and CBT were delivered as group therapies in this study, it was necessary 
to accumulate a cohort of 6 to 12 individuals before the treatment groups could begin. 
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Participants in group cohorts were randomized with simple random assignment to MORE 
(N=64), CBT (N=64), or TAU (N=52). Simple random assignment was conducted by the 
first author using Research Randomizer software (Urbaniak & Plous, 2011). The first author, 
who was blinded to subjects’ identities and uninvolved in research assessments, gave the 
random assignment table to the study coordinator, who then assigned participants to 
treatment groups. Over the course of 4 years, 27 cohorts (average N per cohort=7.0±1.3) 
completed one of the three, 10-week treatment conditions. Following the 10-week 
intervention conditions, participants completed the same set of questionnaires in a post-
treatment assessment session administered by a research assistant who was blinded to 
treatment allocation, after which they all received TAU. All study procedures were approved 
by University of North Carolina-Chapel Hill IRB.
Treatment-as-usual—TAU in the modified therapeutic community primarily consisted 
of: participation in a therapeutic milieu; psychoeducation on topics related to addiction; 
client-centered, supportive-expressive group therapy; and coping skills groups (Monti & 
Rohsenow, 1999). TAU was provided for approximately 2 hours each day.
MORE—MORE unites complementary aspects of mindfulness training, third-wave 
cognitive-behavioral therapy, and principles from positive psychology into an integrative 
intervention strategy. Techniques drawn from these therapeutic approaches were integrated 
into a manualized 10-session group intervention designed to address the pathogenic factors 
implicated in addiction and psychological distress. MORE sessions involved mindfulness 
training to target automatic habit behavior and foster nonreactivity; positive reappraisal 
training to regulate negative emotions and foster a sense of meaningfulness in life; and 
training in savoring pleasant events and emotions to ameliorate deficits in natural reward 
processing and positive affectivity. Per the MORE treatment manual (Garland, 2013), 
sessions offered instruction in applying mindfulness and related skills to the following 
topics: awareness of automaticity in addiction; disrupting the link between negative 
emotions and addictive behavior through reappraisal; refocusing attention from stress and 
craving to savor pleasant experiences; regulating craving through mindful attention and 
awareness; decreasing craving through mindful stress reduction; promoting acceptance 
instead of suppression of experience; awareness of the impermanence of the body; mindful 
relationships; interdependence and meaning in life; and developing a mindful recovery plan. 
Mindfulness training involved mindful breathing and body scan techniques, with an 
emphasis on developing metacognitive awareness and attentional control. MORE 
participants were asked to engage in daily 15-minute mindfulness practice on their own. To 
conform with standard of care at the therapeutic community (i.e., TAU), group sessions 
were 2 hours in length and were administered by a Masters-level clinical social worker who 
had practiced mindfulness for >5 years and had clinical experience offering mindfulness 
training to persons with psychiatric disorders. This individual was supervised weekly by the 
first author (the developer of MORE).
Cognitive-Behavioral Therapy—We implemented a 10 session group CBT intervention 
to match the MORE intervention as much as possible in terms of time-in-treatment. This 
intervention provided training in cognitive, behavioral, and interpersonal coping skills 
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delivered content from the Seeking Safety treatment manual on the following topics 
(Najavits, 2002): safety; PTSD: taking back your power; detaching from emotional pain; 
when substances control you; compassion; honesty; recovery thinking; setting boundaries in 
relationships; healing from anger; termination. To match MORE and TAU sessions in 
length, CBT group sessions were 2 hours long, and participants were asked to do daily 
homework to meet “commitments” which they set at the end of each session (Najavits, 
2002). The amount of time spent per day on commitments varied considerably depending on 
the nature of the commitment. CBT was implemented by Master’s-level clinical personnel 
with experience in treating individuals with addiction, trauma, and psychiatric disorders. 
Clinical supervision was provided weekly by an experienced licensed psychotherapist with 
training in CBT.
Treatment fidelity—Treatment fidelity was monitored in a similar fashion among the 
MORE and CBT groups. Group facilitators used structured manuals with treatment 
implementation protocols, completed fidelity assessment checklists after each session, and 
met weekly with clinical supervisors. Fidelity assessment for the CBT group included an 
adapted version of the Seeking Safety Adherence Scale (Najavits & Liese, 2000) and fidelity 
for MORE was assessed with a comparable unpublished fidelity checklist, which tapped the 
extent to which facilitators: provided information about using mindfulness and reappraisal 
skills to cope with addiction and psychological distress; followed a common structure across 
sessions; practiced the application of mindfulness and other skills; displayed empathy; and 
created a safe and supportive atmosphere in the group. Items tapping intervention adherence 
and process variables on both fidelity assessment checklists were rated on a 0–3 scale, with 
higher scores indicating greater adherence. Clinical supervisors debriefed therapists and 
reviewed audio-recorded sessions to monitor therapist adherence to the MORE and Seeking 
Safety treatment manuals. Any deviations from the treatment manuals were communicated 
weekly prior to the next session during clinical supervision and corrected by the therapist in 
successive sessions. Minor deviations were observed infrequently, and adherence improved 
over time; no major deviations were noted.
Measures
Trauma history—Participants were asked whether or not they had ever experienced each 
of 9 traumatic events in their lifetime, including: “witnessed someone severely injured or 
killed in person”; “having been badly hurt or in danger of being badly hurt”; “had something 
very bad or terrifying happen to you”; “hit by someone who was trying to hurt you”; “been 
mugged by with a weapon or by force”; “attacked with a weapon or by someone trying to 
hurt or kill you”; “witnessed someone be severely beaten”; “been sexually touched against 
your will”; and “forced to do sex acts against your will.” These question items have been 
used to assess trauma history in individuals with substance use disorders in prior studies 
(Garland & Roberts-Lewis, 2013).
Craving—Substance craving was assessed with an adapted version of the Penn Alcohol 
Craving Scale (PACS) (Flannery, Volpicelli, & Pettinati, 1999), modified to assess craving 
for alcohol and other psychoactive substances. The original PACS includes five question 
items that assess the duration, frequency and intensity of craving for alcohol on a 7-point 
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scale. In the version adapted for this study the item structure was maintained for the original 
five items but an additional five items were rephrased to inquire about craving for drugs 
other than alcohol. For Example item 1 of PACS “How often have you thought about 
drinking or how good a drink would make you feel?” was modified to “How often have you 
thought getting high, or about how good getting high would make you feel?” These adapted 
items were summed to create a total drug craving score. Then the adapted drug craving 
items were summed with the alcohol craving items to compute a total substance craving 
score across all 10 items (α = .93). This substance craving version of the PACS has been 
validated in several studies (Garland & Roberts-Lewis, 2013; Garland, Roberts-Lewis, 
Kelley, Tronnier, & Hanley, 2014; Witkiewitz & Bowen, 2011).
Post-traumatic stress symptoms—Post-traumatic stress symptoms were assessed with 
the 17-item PTSD Checklist-Civilian version (PCL-C) (Weathers et al., 1993). Participants 
rated how much they had been bothered by PTSD criterion symptoms as outlined by the 
DSM-IV over the past month. A total post-traumatic stress symptom score was calculated by 
summing responses to each item (3=.92). Responses on the PCL-C reflected post-traumatic 
stress symptoms resulting from the experience of traumatic events endorsed on the 
abovementioned measure of trauma history. The PCL was also used to determine partial 
PTSD diagnosis, as evidenced by meeting criteria for 2 out of 3 PTSD symptom clusters 
assessed on this scale.(Mylle & Maes, 2004) Lastly, the PCL was used to establish the 
presence of subthreshold PTSD symptoms, defined as the presence of some PTSD 
symptoms, but with too few to meet criteria for a full or partial PTSD diagnosis (Cukor, 
Wyka, Jayasinghe, & Difede, 2010).
Psychiatric distress—The depression (α = .87) and anxiety subscales (α = .88) of the 
Brief Symptom Inventory (BSI) (Derogatis & Melisaratos, 1983) were used to measure to 
what degree participants were currently distressed by symptoms like “Feeling fearful” and 
“Feelings of guilt.”
Dispositional mindfulness—The Five Facet Mindfulness Questionnaire was used to 
measure dispositional mindfulness (Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006). 
This scale is comprised of 39 items tapping to what extent participants endorse experiencing 
various facets of mindfulness: nonreactivity to inner experience (tapped by items such as “I 
watch my feelings without getting lost in them”), observing and attending to experience (“I 
pay attention to sensations, such as the wind in my hair or the sun on my face”), describing 
and discriminating emotional experiences (“I’m good at finding words to describe my 
feelings”), nonjudging of experience (“I tell myself I shouldn’t be feeling the way that I am 
feeling”), and acting with awareness (“I find myself doing things without paying attention”). 
Items are summed to produce a total dispositional mindfulness score (α = .92).
Positive and negative affect—The positive (α = .94) and negative affect subscales (α 
= .93) from the 20-item Positive and Negative Affect Schedule (PANAS) (Watson, Clark, & 
Tellegen, 1988) were used to assess the frequency of positive and negative affect “over the 
past week.” Responses on these items were summed to compute global positive and negative 
affect scores.
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Readiness to change—Readiness to change was measured with the 32-item version of 
the University of Rhode Island Change Assessment (URICA; α = .72) (DiClemente, 
Schlundt, & Gemmell, 2004). Following DiClemente et al., the readiness score was 
computed by calculating means for the precontemplation, contemplation, action, and 
maintenance items, and then subtracting the precontemplation mean from the summation of 
other items. Readiness to change was assessed at the pre-treatment and used as a covariate in 
outcome analyses.
Statistical analysis
Intention-to-treat (ITT) analyses were conducted on the entire randomized sample (N=180). 
Outcome data were missing for 28.9% of participants due to study attrition (there were no 
significant between-groups differences in dropout rate). Non-significant t-tests and chi-
square statistics indicated there were no significant differences between participants who 
dropped out vs. those who completed the study across demographic or clinical variables. To 
analyze patterns of missing data in study outcome variables, we performed Little’s MCAR 
test (Little, 1988). The non-significant chi-square value and the pattern of missing data were 
consistent with being missing completely at random (MCAR). To reduce potential bias 
resulting from listwise deletion or last-observation carried forward techniques, hypothesis 
testing was conducted using a repeated-measures linear mixed model approach, which is 
considered preferable to other methods of dealing with missing data (Singer & Willett, 
2003). All models were estimated with maximum likelihood methods, which estimate the 
variance-covariance matrix for all available data, including data from cases assessed at only 
one time point.
Repeated-measures mixed models were computed to test our hypotheses that MORE would 
outperform Seeking Safety and TAU. These mixed models accounted for the variability 
associated with the nesting of multiple observations (i.e., pre- and post-intervention 
assessments; Level 1) within participants (Level 2) within group cohorts (Level 3). The 
random effects aspect of these models affords the structure necessary to account for 
clustering that may exist between individuals nested within each group cohort. In analysis 
models, we treated treatment condition (dummy coded into two planned contrasts of MORE 
vs. CBT and MORE vs. TAU), time, and cohort as fixed effects. Primary analyses modeled 
time as a repeated measure, treatment condition, and a treatment X time interaction term, 
with the interaction term being the main parameter of interest. We controlled for readiness to 
change because participants had a wide range of motivations for entering treatment. Some 
participants had been in prison following being homeless, and thus were adjudicated and 
sent to the therapeutic community on an involuntary basis (either compelled to enroll in 
treatment or face a longer prison sentence). Other participants entered into treatment because 
they had nowhere to seek long-term shelter other than the treatment facility. Others were 
compelled by their families to seek treatment. Still others entered treatment out of a desire to 
pursue recovery from addiction and mental health disorders. Given the wide range of 
motivations and the great variation in readiness to change (see Table 1), we used pre-
intervention readiness to change as a covariate in subsequent analyses.
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Two levels of random effects were included: the first level had a random intercept for 
individuals nested within groups, and the second level had a random intercept for group (for 
a similar cluster RCT modeling approach, see Schnurr et al., 2003). Denominator degrees of 
freedom were obtained by a Satterthwaite approximation (Satterthwaite, 1946). Sensitivity 
analysis of treatment effects on craving controlled for between-groups differences in the 
number of pre-intervention substance use disorder diagnoses, and sensitivity analysis of 
treatment effects on traumatic stress symptoms controlled for between-groups differences in 
pre-intervention PTSD diagnosis. Secondary analyses were conducted to examine within-
group change from pre- to post-treatment. Power analysis was conducted Optimal Design 
software using a medium effect size estimate derived from two earlier trials of MORE 
compared to an active control group (Garland et al., 2010; Garland, Manusov, et al., 2014) 
and the median intra-cluster correlation (ICC; ρ = .04) derived from a meta-analysis of 
cluster RCTs (Eldridge, Ashby, Feder, Rudnicka, & Ukoumunne, 2004). With a medium 
effect size (d = .50) and 27 clusters (9 per condition), and an ICC of ρ = .04, power is .85.
RESULTS
Participant background characteristics are presented in Table 1. The most prevalent 
substance use disorders in the sample were alcohol dependence (45%) and cocaine 
dependence (44%), whereas PTSD was the most common psychiatric disorder − 25% of 
participants met criteria for full PTSD and 37% met criteria for partial PTSD. Other mood 
and anxiety disorders were also fairly common. Nearly half (47%) of participants had 2 or 
more substance use disorders (M = 1.7, SD = 0.8, range 1 – 4). There were no significant 
between-groups differences in the average number of substance use disorder diagnoses, p = .
35. In addition, all participants reported experiencing at least one type of traumatic event in 
their lives. Participants reported having experienced a wide range of traumatic incidents: 
81.1% reported having been struck by someone who had attempted to hurt them; 77% 
experienced a terrifying event; 76% witnessed someone be beaten; 64% witnessed someone 
severely injured or killed; 64% had been mugged with a weapon; 64% had been attacked by 
a weapon by someone trying to hurt or kill them; and 25% had been sexually assaulted or 
raped. On average, participants had experienced 5.2 (SD = 1.7) different categories of 
traumatic life events and there were no significant between-groups differences in trauma 
exposure (p = .17). Many participants also had extensive histories of involvement in the 
criminal justice system; the mean number of lifetime months spent incarcerated was 40.1 
(SD = 55.9).
Primary Outcomes
Table 2 presents descriptive statistics for outcomes by intervention condition and time, 
whereas Table 3 presents results of linear mixed modeling analyses. Significant fixed effects 
of time were observed for craving (p = .01), such that across all three treatment conditions, 
participants improved in craving over the 10 weeks of treatment. The treatment X time 
interaction term indicated that MORE was associated with significantly greater decreases in 
craving than CBT (p = .03). There were no significant differences between MORE and TAU 
on changes in craving (p = .18). However, in a sensitivity analysis controlling for extent of 
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polysubstance use at pre-treatment, participants in MORE reported significantly less craving 
than Seeking Safety (p = .02) and TAU (p = .04).
While the fixed effect of time was non-significant for post-traumatic stress symptoms, 
significant treatment X time interactions were observed, such that MORE was associated 
with greater decreases in post-traumatic stress than CBT (p = .04), and TAU (p = .05). 
Controlling for presence vs. absence of PTSD diagnosis at pre-treatment, MORE was 
associated with significantly greater decreases in post-traumatic stress symptoms in this 
subsample than CBT (p = .04), but not TAU (p = .06). Additional subanalyses of the sample 
meeting full PTSD criteria revealed the same pattern of results – MORE was associated with 
significantly greater reduction in PTSD symptoms than CBT, but not TAU.
Significant fixed effects of time were observed for symptoms of depression (p < .001) and 
anxiety (p = .01), such that across all three treatment conditions, participants improved in 
these domains of psychiatric distress over the 10 weeks of treatment. However, there were 
no significant between-group differences in symptoms of depression and anxiety over time. 
Furthermore, CBT and TAU did not significantly differ with regard to changes in craving or 
post-traumatic stress symptoms.
Secondary Outcomes
Significant treatment X time interactions were observed for dispositional mindfulness, such 
that MORE was associated with greater increases in dispositional mindfulness than CBT (p 
< .001) and TAU (p = .004). Participants in MORE also reported significantly greater 
increases in positive affect than TAU (p = .04). Similarly, MORE was associated with 
significantly greater decreases in negative affect than CBT (p = .04).
With regard to the comparison of MORE and CBT, 4/7 outcomes were significantly 
different, and 3/7 outcomes were significantly different between MORE and TAU. 
Additional analyses examined change from pre- to post-treatment within each treatment 
condition (Table 2). Among MORE participants, there were significant improvements in 
craving, post-traumatic stress, symptoms of depression and anxiety, mindfulness, and 
positive and negative affect.
Changes in Mindfulness as Therapeutic Mechanism
Changes in dispositional mindfulness were significantly negatively correlated with changes 
in craving (r = −.43, p <.001) and post-traumatic stress symptoms (r = −.37, p < .001). To 
examine mindfulness as a therapeutic mechanism, two path analyses were conducted with a 
dummy coded treatment variable (MORE vs. other treatments) as the independent variable, 
changes in craving and PTSD as dependent variables, and changes in mindfulness as a 
mediator (see Figure 2). Sobel test statistics (craving Sobel p = .01; post-traumatic stress 
Sobel p = .02) indicated the presence of a significant indirect effect of changes in 
mindfulness on these clinical outcomes (see Figure 2a and 2b).
Garland et al. Page 10
Behav Res Ther. Author manuscript; available in PMC 2017 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Treatment Fidelity and Attendance Data
Regarding CBT fidelity scores, adherence was adequate, with means as follows on a 0–3 
scale: on intervention items, 2.5 (SD = 0.4); on process items, 2.7 (SD = 0.4). Regarding 
scores on the MORE fidelity checklist, adherence was also adequate, with means as follows 
on a 0–3 scale: on intervention items, 2.9 (SD = 0.2); on process items, 2.8 (SD = 0.3). 
Because attendance of treatment groups was mandatory according to therapeutic community 
rules, attendance was high and there were no significant between-groups differences 
observed: CBT participants attended on average 9.1 (SD = 1.9) sessions, whereas MORE 
participants attended on average 9.0 (SD = 2.0) sessions.
DISCUSSION
This pragmatic trial represents the first head-to-head comparison of MORE against CBT for 
co-occurring psychiatric and substance use disorders. Results from this trial indicate that 
MORE was associated with modest yet statistically significant improvements in craving, 
post-traumatic stress symptoms, and positive and negative affect from pre- to post-treatment. 
Importantly, we identified a significant indirect effect of MORE on craving and post-
traumatic stress through increased dispositional mindfulness, suggesting that this 
intervention produced therapeutic effects by virtue of its ability to enhance mindful 
awareness in everyday life. Though the observed effect sizes ranged from small to moderate, 
these positive outcomes are notable, in that participants suffered from multiple 
vulnerabilities, including psychiatric disturbance, trauma, addiction, incarceration, and 
homelessness. Also, people residing in therapeutic communities often evidence 
improvements in mental health and addiction symptoms (Magor-Blatch, Bhullar, Thomson, 
& Thorsteinsson, 2014), so demonstrating effects over and above TAU is often difficult in 
this population; nonetheless, MORE outperformed TAU across several domains.
In this clinically-complex sample of individuals with COD, participation in MORE was 
associated with reduced craving for drugs and alcohol. MORE provides training in a twofold 
technique for coping with craving. First, patients are instructed to cultivate metacognitive 
awareness of the craving experience, using mindfulness to deconstruct the experience into 
its constituent sensorial, affective, and cognitive subcomponents. If craving becomes too 
intense, patients are instructed to reorient attention to the sensation of breathing, as a means 
of disrupting rumination and engaging parasympathetic regulation. Once arousal has been 
titrated to a more manageable level, the individual is taught to refocus attention back to the 
experience of craving. Following this attentional process, patients are taught to consciously 
contemplate the negative consequences of satiating the craving, as well as to anticipate the 
positive consequences of remaining abstinent. This this dual-stage procedure may engage 
top-down, conscious cognitive control over bottom-up, automatic addictive impulses, 
subserved by activation of prefrontal-striatal brain circuits (Garland, Froeliger, & Howard, 
2013).
MORE provides a similar approach to regulate negative thoughts and emotions in the 
context of stress, whereby individuals are instructed to first become aware of distressing 
mental contents, and then to re-orient attention to the breath as a means of disrupting 
perseverative cognition (e.g., catastrophizing and ruminating) on the stressor. Once the 
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automatic emotional reaction is interrupted, the cognitive flexibility afforded by the practice 
of mindfulness may increase access to an expanded set of information regarding the 
meaning of the stressor from which alternative appraisals can be generated. Participants are 
taught to oscillate between mindfully disengaging from negative automatic appraisals and 
generating positive reappraisals to reduce psychological distress and motivate healthy 
coping behavior. In this sense, MORE uses mindfulness training to facilitate cognitive 
reappraisal; this potentially synergistic “mindful reappraisal” approach may have led to the 
observed reduction in post-traumatic stress. In that regard, more frequent use of cognitive 
reappraisal predicts attenuated PTSD symptoms (Boden, Bonn-Miller, Kashdan, Alvarez, & 
Gross, 2012), and theory and empirical evidence indicate that mindfulness promotes positive 
reappraisals of life adversity to enhance post-traumatic growth and eudaimonic well-being 
(Garland, Farb, Goldin, & Fredrickson, in press). To that latter point, MORE was associated 
with significant within-group improvements in positive and negative affect, as well as in 
symptoms of depression and anxiety. The affective benefits of MORE may stem from its 
integration of mindfulness and reappraisal, as well as from its emphasis on mindful 
savoring, the process of attending to and appreciating pleasant events and the positive 
emotions that flow from them (Bryant & Veroff, 2007). Future studies should measure 
reappraisal and savoring as potential treatment mediators.
It should be noted that the observed clinical outcomes were measured after 10 weeks of 
treatment. The duration of these therapeutic benefits is unknown. It is quite possible that the 
observed significant-between groups differences might have dissipated at a later time point, 
or that CBT and/or TAU might have had more pronounced treatment effects at a later 
follow-up. Contrary to our expectations, in the present study, CBT was not found to 
significantly improve craving or post-traumatic stress symptoms. However, these null results 
are consistent with a recent meta-analysis of RCTs for people with co-occurring substance 
use disorders and PTSD which found that on average, non-trauma focused group CBT 
interventions (those that do not directly process trauma memories) do not produce 
statistically significant effects on traumatic stress or drug-related outcomes in this 
population, and even for efficacious treatments, effect sizes are small (Roberts, Roberts, 
Jones, & Bisson, 2015). However, this meta-analysis did not take patient complexity into 
account, and when doing so, findings are highly divergent with regard to what treatments 
work best (Gerger, Munder, & Barth, 2014). It is also possible that the low-dose provision of 
coping skill training to TAU may have obscured differences between the CBT and TAU 
groups. It should be noted that though MORE outperformed CBT on PTSD symptom 
reduction, the observed between-groups differences were quite small, and statistical power 
for assessing this outcome may have been somewhat limited given that only 62% of the 
sample met criteria for full or partial PTSD. Also, the psychometrics of the trauma history 
measure used in the present study have not been evaluated.
In addition, the present study was limited by a lack of biochemical measures of abstinence. 
To assess effects of the study interventions on drug and alcohol use, it would have been 
ideal if biochemical verification of abstinence was conducted consistently at regular time 
intervals. However, self-reports of abstinence were corroborated by random urinalyses 
conducted at the TC on an as needed basis, as well as through daily observation by program 
staff. According to this data, 98% of participants remained abstinent over the course of the 
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study. The high rate of abstinence may have been due to the fact that participants (who had 
been previously homeless) were residents in a long-term therapeutic community which 
provided housing, vocational training, and an array of supports to those who remained 
abstinent. Study findings may not be generalizable to individuals with COD with lower 
levels of motivation who would not be willing to enroll in such an extensive, long-term 
treatment program. Future studies should quantify distal outcomes through biochemical 
confirmation of abstinence and structured diagnostic interviews at 12- and 24-month follow-
ups, to determine the impact of treatment of substance use and psychiatric disorder status.
In spite of these limitations, the present study, which compared MORE to an empirically-
supported CBT intervention for formerly homeless individuals with severe substance use 
and psychiatric disorders, provides evidence that MORE is associated with modest but 
statistically significant therapeutic effects on factors integral to the co-occurrence of 
addiction, emotional distress, and trauma. Thus, study findings suggest that MORE, as an 
integrative therapy designed to enhance self-regulatory capacity, may be a promising 
treatment for some of the most vulnerable and marginalized individuals in our society: those 
afflicted by poverty, violence, and a range of complex, intersecting clinical conditions.
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• There is a high comorbidity between substance use and psychiatric disorders
• CBT interventions may efficiently target co-occurring disorders
• Mindfulness-Oriented Recovery Enhancement (MORE) is a novel treatment
• MORE reduced craving and traumatic stress symptoms more than CBT
• Therapeutic effects of MORE were statistically mediated by mindfulness
• MORE holds promise as a treatment for co-occurring disorders
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Figure 1. 
Study flow diagram.
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Figure 2. 
The indirect effect of Mindfulness-Oriented Recovery Enhancement on craving (Figure 2a) 
and post-traumatic stress symptoms (Figure 2b) through increasing dispositional 
mindfulness was statistically significant.
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Table 1
Description of Study Sample (N = 180).
MORE (N = 64) CBT (N = 64) TAU (N = 52)
Age 37.7 (10.4) 36.5 (11.2) 38.7 (9.8)
Race
 White 26 (40%) 28 (44%) 22 (42%)
 Black 29 (45%) 28 (44%) 23 (44%)
 Other 9 (14%) 8 (12%) 7 (14%)
Lifetime months incarcerated 45.4 (59.9) 38.1 (54.7) 35.7 (52.8)
Readiness to Change
 Pre-contemplation 11 (17%) 11 (17%) 6 (12%)
 Contemplation 38 (59%) 36 (56%) 29 (56%)
 Preparation 15 (23%) 17 (27%) 13 (25%)
 Not answered 0 (0%) 0 (0%) 4 (7%)
Substance Use Disorder Diagnosis
 Alcohol dependence 30 (47%) 23 (36%) 28 (40%)
 Cocaine dependence 27 (42%) 26 (41%) 27 (52%)
 Opioid dependence 16 (25%) 23 (36%) 10 (19%)
 Cannabis dependence 12 (19%) 19 (30%) 16 (31%)
 Sedative dependence 3 (5%) 2 (3%) 0 (0%)
 Amphetamine dependence 2 (3%) 2 (3%) 1 (2%)
 Cocaine abuse 1 (2%) 4 (6%) 2 (4%)
 Alcohol abuse 3 (5%) 6 (9%) 1 (2%)
 Cannabis abuse 3 (5%) 3 (5%) 0 (0%)
 Hallucinogen abuse 0 (0%) 3 (5%) 1 (2%)
 Any drug use disorder dx 48 (75%) 55 (85%) 36 (69%)
 Number of drug use disorder dx 1.30 (.50) 1.46 (.61) 1.42 (.61)
 Any alcohol + drug use disorder dx 24 (38%) 19 (30%) 20 (38%)
 Number of total alcohol + drug use dx 1.66 (.72) 1.69 (.74) 1.70 (.80)
Post-Traumatic Stress Diagnosis
 Full post-traumatic stress disorder 13 (20%) 17 (27%) 15 (29%)
 Partial post-traumatic stress disorder 19 (30%) 29 (44%) 19 (37%)
Psychiatric Disorder Diagnosis
 Major depressive disorder 6 (9%) 5 (8%) 9 (17%)
 Bipolar disorder 3 (5%) 4 (6%) 4 (8%)
 Generalized anxiety disorder 5 (8%) 7 (11%) 2 (4%)
 Social phobia 6 (9%) 1 (2%) 6 (12%)
 Panic disorder 1 (2%) 1 (2%) 2 (4%)
 Other mood or anxiety disorder 19 (30%) 18 (28%) 11 (21%)
 Antisocial personality disorder 4 (6%) 1 (2%) 2 (4%)
 Other 7 (11%) 10 (16%) 1 (2%)
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Note: For the sake of parsimony, multiple diagnoses were collapsed into higher-order categories when appropriate: e.g., major depressive disorder 
and bipolar disorder categories include all subtypes and specifiers, and the table entry “other mood or anxiety D/O” comprises DSM-IV TR 
diagnoses 292.84; 292.89; 296.90; 300.00; 300.29; 300.4; and 311.
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